Azitra, Inc. (@azitrainc) header
Azitra, Inc. (@azitrainc) profile picture

Precision dermatology powered by microbial and genetic engineering Developing novel therapeutics to treat adverse skin conditions and disease

Branford, CT
Joined November 2015
Photo by Azitra, Inc. (@azitrainc)Photo by Azitra, Inc. (@azitrainc)Photo by Azitra, Inc. (@azitrainc)Photo by Azitra, Inc. (@azitrainc)Photo by Azitra, Inc. (@azitrainc)Photo by Azitra, Inc. (@azitrainc)Photo by Azitra, Inc. (@azitrainc)Photo by Azitra, Inc. (@azitrainc)Photo by Azitra, Inc. (@azitrainc)Photo by Azitra, Inc. (@azitrainc)
From our CEO, Francisco Salva, in today's release: Read the full announcement: prnewswire.com/news-releases… #ATR04 #ClinicalTrials #Biotechnology #PrecisionDermatology
1
2
87
More from our CEO in our recent announcement - @azitrainc announces advances ATR-04 Phase 1/2 Clinical Trial to Cohort 2 Following Safety Review Committee Clearance. See here: ir.azitrainc.com/news-releas… $AZTR #PrecisionDerm #Dermatology #SkinCare #CancerRash #EGFRiRash
1
330
@azitrainc platform is designed to engineer beneficial skin bacteria, such as S. epidermidis, to deliver therapeutic proteins and molecules directly to affected skin. Learn more here: azitrainc.com/technology/ #PrecisionDermatology #SyntheticBiology #Biotech #Dermatology
76
Be sure to check us out next week at the H.C. Wainwright 28th Annual Global Investment Conference @azitrainc #PrecisionDerm #CancerRash #SkinDisorder #SkinCare #SkinElasticity #Cosmeceuticals $AZTR ir.azitrainc.com/news-releas…
114
@azitrainc to Present at the H.C. Wainwright 28th Annual Global Investment Conference #PrecisionDerm #CancerRash #SkinCare #SkinElasticity $AZTR ir.azitrainc.com/news-releas…
115
#Cancer Therapy-Associated #Rash is a big problem - earliest to occur, most predictable, & most common adverse event of EGFR inhibitors - papulopustular rashes, affecting 60-90% of patients. Learn more here azitrainc.com/pipeline/#ATR-… #CancerRash #PrecisionDerm
90
More about #filaggrin for #dermatology and #skinhealth - learn more about our ATR-COSF program - supernatant of filaggrin-producing S. epidermidis for #cosmeceuticals. Translating @azitrainc's cutting edge science to potentially benefit consumers $AZTR azitrainc.com/pipeline/
1
159
More about our ATR-COSF - recombinant filaggrin protein program representing the first consumer-facing expansion of @azitrainc's #SyntheticBiology platform, adapting #PrecisionDermatology technology for the cosmeceutical market $AZTR Read more about it: azitrainc.com/pipeline/#atr-…
364
Azitra, Inc. retweeted
In an exclusive interview with The Fly, @azitrainc CEO spoke about the company's expanding #strategy, the science behind its recombinant #protein programs and the commercial potential of ATR COSF. More in "Meet the Company," from @theflynews $AZTR thefly.com/AZTR
1
1,323
ICYMI - Personal Care Insights covered our announcement last week - @azitrainc filaggrin ingredient shows #antiwrinkle potential personalcareinsights.com/new… $AZTR #Cosmeceuticals #SkinBarrier #Dermatology #Skincare
184
Thanks to Personal Care Insights for covering our latest: Azitra filaggrin ingredient shows anti-wrinkle potential personalcareinsights.com/new… $AZTR #Cosmeceuticals #SkinBarrier #Dermatology #Skincare
148